Google Search
Lecture on Proteomics and Cancer Biomarkers

Endometrial cancer -- a malignancy of the epithelium in the uterus -- is the fourth most common cancer found among women in North America. The Centre for the Neurobiology of Stress (CNS) at the University of Toronto Scarborough presents a talk by a leading researcher in the field.  "Proteomics and Cancer Markers" features Dr. Michael Siu, a leader in the field of proteomics and the Founder and Director of the Centre for Research in Mass Spectrometry at York University. Under his leadership, scientists have discovered a panel of more than 10 cancer markers that may be used to eventually diagnose endometrial cancer. The CNS lecture will take place on Monday, May 14 at 12 noon in S-403, Sciences Meeting Room. Everyone is welcome.

Dr. Siu will talk about Mass-Tagging Approaches to the Discovery and Identification of Endometrial Cancer Biomarkers and their Subsequent Validation Using Immunochemistry.

Cancer of the uterine epitehelium, or endometrial carcinoma (EMCa), affects 3,500 women annually. Advances in mass spectrometry-based proteomic techniques permit the recognition of both normal and diseased tissues and cellular phenotypes by means of biomarkers in protein/peptide profiles. These biomarkers may then be used in the screening or diagnosis of disease through serum, cytologic, or tissue testing.

Join us at the CNS lecture series to hear about advances in this field.

© University of Toronto Scarborough